|
|
||||||||
1Department of Physiology, University of Otago, Dunedin, New Zealand; 2Peninsula Private Sleep Laboratory, Sydney, New South Wales, Australia; 3Institute of Medicine and Patan Hospital, Katmandu, Nepal; and 4Department of Medicine, University of Sydney, Sydney, New South Wales, Australia
Submitted 18 August 2006 ; accepted in final form 16 October 2006
We tested the hypothesis that, following exposure to high altitude, cerebrovascular reactivity to CO2 and cerebral autoregulation would be attenuated. Such alterations may predispose to central sleep apnea at high altitude by promoting changes in brain PCO2 and thus breathing stability. We measured middle cerebral artery blood flow velocity (MCAv; transcranial Doppler ultrasound) and arterial blood pressure during wakefulness in conditions of eucapnia (room air), hypocapnia (voluntary hyperventilation), and hypercapnia (isooxic rebeathing), and also during non-rapid eye movement (stage 2) sleep at low altitude (1,400 m) and at high altitude (3,840 m) in five individuals. At each altitude, sleep was studied using full polysomnography, and resting arterial blood gases were obtained. During wakefulness and polysomnographic-monitored sleep, dynamic cerebral autoregulation and steady-state changes in MCAv in relation to changes in blood pressure were evaluated using transfer function analysis. High altitude was associated with an increase in central sleep apnea index (0.2 ± 0.4 to 20.7 ± 23.2 per hour) and an increase in mean blood pressure and cerebrovascular resistance during wakefulness and sleep. MCAv was unchanged during wakefulness, whereas there was a greater decrease during sleep at high altitude compared with low altitude (9.1 ± 1.7 vs. 4.8 ± 0.7 cm/s; P < 0.05). At high altitude, compared with low altitude, the cerebrovascular reactivity to CO2 in the hypercapnic range was unchanged (5.5 ± 0.7 vs. 5.3 ± 0.7%/mmHg; P = 0.06), while it was lowered in the hypocapnic range (3.1 ± 0.7 vs. 1.9 ± 0.6%/mmHg; P < 0.05). Dynamic cerebral autoregulation was further reduced during sleep (P < 0.05 vs. low altitude). Lowered cerebrovascular reactivity to CO2 and reduction in both dynamic cerebral autoregulation and MCAv during sleep at high altitude may be factors in the pathogenesis of breathing instability.
autoregulation; polysomnography; sleep-disordered breathing
This article has been cited by other articles:
![]() |
P. N. Ainslie, S. Ogoh, K. Burgess, L. Celi, K. McGrattan, K. Peebles, C. Murrell, P. Subedi, and K. R. Burgess Differential effects of acute hypoxia and high altitude on cerebral blood flow velocity and dynamic cerebral autoregulation: alterations with hyperoxia J Appl Physiol, February 1, 2008; 104(2): 490 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Peebles, L. Celi, K. McGrattan, C. Murrell, K. Thomas, and P. N. Ainslie Human cerebrovascular and ventilatory CO2 reactivity to end-tidal, arterial and internal jugular vein PCO2 J. Physiol., October 1, 2007; 584(1): 347 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Duffin Measuring the ventilatory response to hypoxia J. Physiol., October 1, 2007; 584(1): 285 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. A. Jansen, A. Krins, B. Basnyat, J. A. Odoom, and C. Ince Role of the altitude level on cerebral autoregulation in residents at high altitude J Appl Physiol, August 1, 2007; 103(2): 518 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Cummings, M. Swart, and P. N. Ainslie Morning attenuation in cerebrovascular CO2 reactivity in healthy humans is associated with a lowered cerebral oxygenation and an augmented ventilatory response to CO2 J Appl Physiol, May 1, 2007; 102(5): 1891 - 1898. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Swenson and L. J. Teppema Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story J Appl Physiol, April 1, 2007; 102(4): 1305 - 1307. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |